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Objectives. We investigated whether heart rate variability, the 
signal-averaged electrocardiogram (ECG), ventricular arrhyth- 
mias and left ventricular ejection fraction predict the mechanism 
of cardiac death after myocardial infarction. 
Background. Postinfarction risk stratification studies have 
almost exclusively focused on predicting the risk of arrhythmic 
death. The factors that identify and distinguish persons at risk for 
arrhythmic and nonarrhythmic death are poorly known. 
Methods. Heart rate variability, the signal-averaged ECG, 
ventricular arrhythmias and left ventricular ejection fraction were 
assessed in 575 survivors of acute myocardial infarction. The 
patients were followed up for 2 years; arrhythmic and nonarrhyth- 
mic cardiac deaths were used as clinical end points. During the 
follow-up period, 47 cardiac deaths occurred, 29 (62%) arrhythmic 
and 18 (38%) nonarrhythmic. 
Results. All risk factors were associated with cardiac mortality 
in univariate analysis. With the exception of left ventricular 
ejection fraction, they were also predictors of arrhythmic death. 
Depressed heart rate variability (p < 0.001), ventricular ectopic 
beats (p < 0.001) and low ejection fraction (p < 0.001) were 
related to nonarrhythmic death. In multivariate analysis, de- 
pressed heart rate variability (p < 0.001) and runs of ventricular 
tachycardia (p < 0.05) predicted arrhythmic death. Nonarrhyth- 
mic death was associated with depressed heart rate variability 
(p < 0.001), ventricular ectopic beats (p < 0.001) and low ejection 
fraction (p < 0.01). By selecting patients with depressed heart rate 
variability, long filtered QRS duration or ventricular arrhythmias 
and excluding patients with the lowest ejection fraction, we 
identified a group in which 75% of deaths were arrhythmic. 
Similarly, by selecting patients with a low ejection fraction and 
excluding patients with the lowest heart rate variability, we 
identified a group in which 75% of deaths were nonarrhythmic. 
Conclusions. Arrhythmic death was associated predominantly 
with depressed heart rate variability and ventricular tachycardia 
runs, and nonarrhythmic death with low ejection fraction, yen. 
tricular ectopic beats and depressed heart rate variability. A 
combination of risk factors identified patient groups in which a 
majority of deaths were either arrhythmie or nonarrhythmic. 
(J Am Coll Cardio11996;28:296-304) 
In patients recovering from acute myocardial infarction, iden- 
tification of those at high risk of death is of great clinical 
importance. Great effort has been made to identify high risk 
groups in which further investigation and intervention are 
needed. Several methods uch as determination f heart rate 
variability or baroreflex sensitivity (1-5), the signal-averaged 
electrocardiogram (ECG) (6-9), assessment of ventricular 
arrhythmias during 24-h ECG recording (10-12) and evalua- 
tion of left ventricular dysfunction (12-14) have been shown to 
predict poor outcome in patients recovering from acute myo- 
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cardial infarction. In particular, risk factors determined with 
these techniques have been related to the risk of ventricular 
arrhythmias nd of sudden death (15,16). In addition, patients 
at high risk often have several risk factors (2,3,17,18). Thus, the 
independent contribution of various risk factors on cardiac 
mortality are poorly understood. 
Earlier studies almost exclusively investigated the predic- 
tion of cardiac or arrhythmic death. Only a very few studies 
have focused on identifying patients with a high risk of 
specifically arrhythmic or nonarrhythmic death and on distin- 
guishing between arrhythmic and nonarrhythmic death• Al- 
though arrhythmic deaths account for a great proportion of 
cardiac deaths after myocardial infarction, -40% of deaths are 
nonarrhythmic (14,19,20). Identification of patients at risk of 
death specifically by arrhythmic or nonarrhythmic mechanisms 
is of clinical importance, because these patients may benefit 
from different modes of treatment. Furthermore, when evalu- 
ating the effect of an intervention such as antiarrhythmic 
therapy in clinical trials, it would be useful to recruit patients 
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with a high risk of arrhythmic death and avoid patients with a 
high likelihood of nonarrhythmic death. 
This study evaluated the relation between data on heart 
rate variability, the signal-averaged ECG, ventricular arrhyth- 
mias during 24-h ECG recording and left ventricular function 
and the mechanism of cardiac death in survivors of acute 
myocardial infarction. Specifically, we investigated whether 
combinations ofsuch data could be used to identify selectively 
patients with a high likelihood of arrhythmic or nonarrhythmic 
death. 
Methods  
Patients. The study group consisted of 575 patients aged 
<75 years admitted to St. George's Hospital because of acute 
myocardial infarction. Acute myocardial infarction was diag- 
nosed as described previously (21). From the consecutive 
patients, we excluded those with valvular heart disease, a 
permanent pacemaker, diabetes mellitus, atrial fibrillation or 
left bundle branch block and those who were unable to be 
followed up. 
Study protocol. Before hospital discharge, patients under- 
went a standard investigation protocol including 24-h ECG 
recording, assessment of cardiac systolic function, signal- 
averaged ECG and exercise testing. Patients with a positive 
exercise test response were referred for cardiac atheterization 
and those with a negative response underwent assessment of
left ventricular systolic function by radionuclide scanning. 
Patients gave written, informed consent to participate in the 
study and the protocol was approved by the local Ethics 
Committee. 
Heart rate variability. The 24-h ambulatory ECG record- 
ing was performed by using a two-channel recorder (either 
Reynolds Medical or Marquette Electronics), recording stan- 
dard leads II and CM 5. Treatment with beta-adrenergic block- 
ing agents was interrupted ->48 h before the recording. All 
recordings were analyzed by using the Marquette Laser Holter 
system 8000, and manual editing of RR intervals and QRS 
configuration was used. Heart rate variability was calculated by 
using the triangular index method described elsewhere (4). 
Heart rate variability values were dichotomized at20 U (21). 
Signal-averaged ECG. The signal-averaged ECG was ana- 
lyzed with an ART 1200 EXP device (Arrhythmia Research 
Technology). The high pass filter was set at 40 Hz, and a mean 
of 234 cardiac betas were averaged to achieve atarget standard 
deviation noise level of <0.3 ~V as checked at the time of 
recording. Results of the signal-averaged ECG were consid- 
ered positive if two of three of Simson's criteria (22) were met: 
filtered QRS complex > 120 ms; root-mean-square voltage <25 
/~V during the last 40 ms of the filtered QRS complex; duration 
of the filtered QRS complex >40 ms after the voltage de- 
creased to <40 tzV. 
Ventricular arrhythmias during 24-h ambulatory ECG 
recording. The 24-h ECG recordings were visually checked 
for arrhythmia recognition. The number of ventricular ectopic 
beats during each hour was assessed and the mean value 
calculated. A rate of ventricular ectopic beats >10/h was 
considered abnormal (12). The presence of nonsustained runs 
of ventricular tacbycardia was also examined. A run of ventric- 
ular tachycardia was defined as more than three consecutive 
ventricular ectopic beats with a cycle length <600 ms. 
Left ventricular ejection fraction. In patients who had 
coronary angiography and left ventricular catheterization be- 
fore discharge, left ventricular ejection fraction was calculated 
from left ventricular ventriculographic silhouettes in the right 
anterior oblique view (23). In patients who did not undergo 
cardiac atheterization, ejection fraction was determined from 
radionuclide angiograms recorded in the supine position with 
use of a left anterior oblique view. Ejection fraction was then 
calculated by the multiple-gated method (14). Values for 
ejection fraction were dichotomized at40% (12). 
Follow-up. Patients were followed up in our outpatient 
clinic at 2, 6 and 12 months after infarction and thereafter 
annually for a minimal period of 2 years (range 24 to 76 
months). Total cardiac mortality and arrhythmic and nonar- 
rhythmic ardiac deaths were used as major end points. The 
mode of death was classified according to the criteria of the 
Cardiac Arrhythmia Suppression Trial (CAST) (19,24). Ar- 
rhythmic death was defined as a sudden death, that is, 1) 
instantaneous death within 1 h of the onset of symptoms in a 
patient without evidence of the presence of ischemia or 
progressive heart failure, or 2) death during sleep. An unwit- 
nessed eath in a patient who had a documented history of a 
sustained monomorphic ventricular tachycardia after the index 
myocardial infarction was also considered an arrhythmic death. 
All other cardiac deaths were considered nonarrhythmic. 
Statistical analysis. Comparisons between different groups 
were made by using the Student t test, and one-way analysis of 
variance for continuous variables and the chi-square test for 
categoric variables. The effect of heart rate variability, the 
signal-averaged ECG, ventricular ectopic beats, runs of ven- 
tricular tachycardia and left ventricular ejection fraction on 
cardiac mortality was studied with univariate and multivariate 
logistic regression analysis. A forward stepwise model with a 
PIN (p value for entry) value of 0.05 was used. The removal of 
variables was based on the Wald statistics. 
To stratify 20% of the total patient group with the highest 
propensity for arrhythmic death, we first excluded patients with 
the lowest 5th, 10th, 15th, 20th, 25th and 30th percentile of left 
ventricular ejection fraction; from the remaining patients we 
selected the group with the lowest 20th percentile of heart rate 
variability. The analysis was repeated in a similar way but 
replacing heart rate variability in turns with the highest 20th 
percentile of the signal-averaged ECG, ventricular ectopic 
beats and runs of ventricular tachycardia. In these analyses, the 
signal-averaged ECG, ventricular ectopic beats and ventricular 
tachycardia were converted to continuous variables by means 
of duration of the filtered QRS complex, average number of 
ventricular ectopic beats/h and the maximal number of con- 
secutive ventricular ectopic beats during the 24-h ECG record- 
ing, respectively. 
To identify patients at high risk of nonarrhythmic death we 
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Table 1. Risk Factors and Clinical Outcome During 2-Year 
Follow-Up in Patients With Myocardial Infarction 
Survivors Arrhythmic Death Nonarrhythmic Death 
(n = 520) (n - 29) (n = 18) 
HRV (U) 28.3 + 10.5 18.3 _+ 10.4" 19.0 _+ 14.4" 
SAECG (pos) 21.3% 42.9%]" 36.4% 
VE (>10/h) 14.5% 33.3%:~ 61.1%* 
VT (pos) 12.3% 29.6%~: 22.2% 
LVEF (%) 48.8 _+ 14.4 39.5 _+ 16.0:~ 33.8 _+ 16.4' 
*, ~, ~: - p < 0.001, p < 0.01 or p < 0.05, respectively, versus urvivors. Data 
presented are mean value _+ SD or percent of patients. HRV = heart rate 
variability index; LVEF = left ventricular ejection fraction; pos = positive 
findings; SAECG = signal-averaged lectrocardiogram; VE = ventricular ec- 
topic beats; VT - runs of ventricular tachycardia during 24-b electrocardio- 
graphic recording. 
excluded first patients with the lowest 5th, 10th, 15th, 20th, 
25th and 30th percentiles ofheart rate variability, and from the 
remaining patient group we selected patients with the lowest 
20th percentile of left ventricular ejection fraction. The same 
analysis was repeated by replacing heart rate variability with 
the highest 5th, 10th, 15th, 20th, 25th and 30th percentiles of 
the signal-averaged ECG, ventricular ectopic beats and runs of 
ventricular tachycardia. Finally, we evaluated the distinction 
between arrhythmic and nonarrhythmic mortality when 10%, 
15%, 20%, 25% and 30% of the total patient group was 
stratified by means of combinations of heart rate variability 
and left ventricular ejection fraction. 
All data are expressed as mean value +_SD unless otherwise 
indicated. A p value < 0.05 was considered statistically signif- 
icant. An SPSS package (version 5.0.1) was used for statistical 
analysis. 
Resu l ts  
Clinical characteristics of patients. The mean age of the 
patients on hospital admission was 57.5 -+ 8.9 years (range 25 
to 75); 455 (79%) were men. A Q wave myocardial infarction 
was present in 402 patients (70%), an anterior infarction in 268 
(47%); thrombolytie therapy was given to 311 patients (54%). 
A history of previous myocardial infarction was given by 91 
patients (16%). At the time of discharge, beta-blocker therapy 
was prescribed in 228 patients (40%). 
Mortality during follow-up. Fifty-five patients (9.6%) died 
during the 2-year follow-up period. Eight deaths had noncar- 
diac causes. Thus, there were 47 deaths (8.2%) of cardiac 
origin; 29 (62%) classified as arrhythmic and 18 (38%) as 
nonarrhythmic. 
Univariate determinants of cardiac mortality. Heart rate 
variability. The mean heart rate variability before discharge 
averaged 27.5 _+ 10.9 U (range 2.3 to 71.5). Depressed heart 
rate variability was found in 145 patients (25% of the total 
patient group). Patients with arrhythmic or nonarrhythmic 
death had lower heart rate variability than did survivors (p < 
0.001 for both, Table 1). Heart rate variability did not differ 
between patients with arrhythmic or nonarrhythmic death. 
Table 2. Univariate Predictors ofCardiac Arrhythmic and 
Nonarrhythmic Mortality After Myocardial Infarction 
Mortality 
Cardiac Arrhythmic Nonarrhythmic 
HRV >20 U 8.8 (4.5-16.9)* 7.5 (3.3-16.9)* 8.5 (2.9-24.1)* 
SAECG (pos) 2.4 (1.0-5.6)] 2.6 (1.1-7.8)t 2.0 (0.6-6.9)§ 
VE (>10/h) 4.9 (2.4-8.5)* 2.5 (1.1-5.7)t 8.2 (3.1-21.8)* 
VT (pos) 2.6 (1.3-5.3):~ 2.9 (1.2-6.9)t 1.9 (0.6-5.9)§ 
LVEF <40% 3.0 (1.6-5.5)* 1.8 (0.8-3.9)§ 6.1 (2.1-17.3)* 
*, t, ~, § = P < 0.001, p < 0.01, p < 0.05 or p - NS, respectively. Data presented 
are relative risk (95% confidence interval). Abbreviations as in Table 1. 
In univariate logistic regression analysis, heart rate variabil- 
ity was inversely associated with total cardiac mortality (p < 
0.001) and arrhythmic (p < 0.001) and nonarrbythmic (p < 
0.001) death. Correspondingly, the rate of total cardiac mor- 
tality (p < 0.001), arrhythmic death (p < 0.001) and nonar- 
rhythmic death (p < 0.001) was higher in patients with low 
than in those with normal heart rate variability (Table 2). 
Signal-averaged ECG. A signal-averaged ECG recording 
was available for 358 patients and findings were positive in 82 
(23%). Table 1 demonstrates that signal-averaged ECG results 
were positive in 43% of patients with an arrhythmic death but 
in only 21% of survivors (p < 0.05). The proportion of positive 
signal-averaged ECG results in patients with nonarrhythmic 
death (36%) did not differ from that in survivors. 
In a univariate logistic regression analysis, positive findings 
on the signal-averaged ECG were a predictor of total cardiac 
mortality (p < 0.05) and arrhythmic death (p < 0.001) but not 
of nonarrhythmic death. Finally, positive signal-averaged ECG 
findings were associated with an increased risk of both total 
cardiac deaths (p < 0.05) and arrhythmic death (p < 0.05) 
(Table 2). 
Ventricular arrhythmias. Analysis of the 24-h ECG record- 
ings revealed frequent ventricular ectopic beats in 96 patients 
(17.6%) and nonsustained ventricular tachycardia runs in 74 
(13.5%). Of patients who had an arrhythmic death, 33% had 
ventricular ectopic beats and 30% had runs of ventricular 
tachycardia before hospital discharge, incontrast to 14.5% and 
12.3% of survivors, respectively (p< 0.01 for both, Table 1). In 
addition, a majority (61%) of patients with nonarrhythmic 
death had ventricular ectopic beats during the ambulatory 
ECG recording (Table 1). 
In a univariate regression analysis the presence of frequent 
ventricular ectopic beats was related to total cardiac mortality 
(p < 0.001) and arrhythmic (p < 0.05) and nonarrhythmic (p < 
0.001) death. Correspondingly, patients with ventricular ec- 
topic beats had an increased risk of total cardiac (p < 0.001), 
arrhythmic (p < 0.05) and nonarrhythmic (p < 0.001) mortal- 
ity (Table 2). Runs of ventricular tachycardia also predicted 
the development of cardiac death (p < 0.01) and arrhythmic 
death (p < 0.05), but they did not predict nonarrhythmic 
death. 
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Table 3. Distribution of Risk Factors in Patients at the Time of 
Hospital Discharge After Acute Myocardial Infarction 
HRV SAECG VE VT LVEF 
(<20U) (pos) (>10/11) (pos) (<40%) 
HRV (<20 U) (n = 145) 33% 25% 13% 50% 
SAECG (pos) (n = 82) 37% 28% 17% 39% 
VE (>10/h) (n = 96) 35% 39% 40% 51% 
VT (pos) (n = 74) 23% 31% 51% 46% 
LVEF (<40%) (n = 181) 40% 25% 28% 19% 
Abbreviations as in Table 1. 
Left ventricular ejection fraction. The mean left ventricular 
ejection fraction was 47.8 _+ 14.9% (range 9.0% to 87.0%) 
before hospital discharge. Depressed left ventricular function 
was found in 181 patients (31%). Ejection fraction was lower in 
patients with arrhythmic or nonarrhythmic death than in 
survivors (p < 0.01 and p < 0.001, respectively) but did not 
differ between patients with arrhythmic or nonarrhythmic 
death (Table 1). 
In the univariate logistic regression analysis, depressed left 
ventricular ejection fraction predicted total cardiac (p < 
0.001), arrhythmic (p < 0.05) and nonarrhythmic (p < 0.001) 
mortality. Correspondingly, patients with a low ejection frac- 
tion had a higher ate of total cardiac mortality (p < 0.001) and 
nonarrhythmic death (p < 0.001) than did patients with a 
normal ejection fraction. They also tended to have a higher 
rate of arrhythmic death than patients with normal ejection 
fraction, (p = NS) (Table 2). 
Multivariate determinants of cardiac mortality. Table 3 
shows the distribution of risk factors in our patient group. 
A total of 242 patients (42%) had no risk factors, 177 (31%) 
had one risk factor and 160 (28%) had two or more risk 
factors. 
By using the multivariate logistic regression analysis, we 
found that depressed heart rate variability (p < 0.001), low left 
ventricular ejection fraction (p < 0.05), ventricular ectopic 
beats (p < 0.05) and age (p < 0.05) were determinants of total 
cardiac mortality. Depressed heart rate variability (p < 0.001) 
and the presence of runs of ventricular tachycardia (p < 0.05) 
were the only predictors of arrhythmic death. Finally, de- 
pressed heart rate variability (p < 0.001), ventricular ectopic 
beats (p < 0.001), low left ventricular ejection fraction (p < 
0.01), female gender (p < 0.05) and previous myocardial 
infarction (p < 0.05) were related to nonarrhythmic death. 
Combination of risk factors and the mechanism of cardiac 
death. We studied the use of a combination of two risk factors 
in predicting the mechanism of death. On the basis of univar- 
iate and multivariate analyses, the other risk factor epresented 
propensity of ventricular arrhythmias: depressed heart rate 
variability (trigger of arrhythmias), signal-averaged ECG (sub- 
strate of arrhythmias), presence of ventricular ectopic beats or 
ventricular tachycardia runs (documentation f arrhythmias). 
The second risk factor was left ventricular ejection fraction, 
that is, a risk factor describing left ventricular dysfunction. 
Finally, we analyzed combinations of heart rate variability with 
ventricular ectopic beats and runs of ventricular tachycardia. 
Figure la illustrates that depressed heart rate variability 
was related to total cardiac and arrhythmic mortality in 
patients with a normal (p < 0.001 for both) or low (p < 0.001 
for both) left ventricular ejection fraction. In addition, in 
50 
4O 
3O 
"C 20 
o 
10 
Figure 1. Combination of two risk factors and 
cardiac mortality during 2-year follow-up after 
myocardial infarction. The solid bars illustrate 
arrhythmic mortality and the open bars nonar- 
rhythmic mortality; the cumulative height of the 
bars illustrates total cardiac mortality. Symbols 
above the solid bars indicate significance r lated to o 
arrhythmic mortality and symbols above the open 
bars significance r lated to nonarrhythmic mortal- 
ity. *p < 0.05, **p < 0.01, ***p < 0.001 versus the 
group with no risk factors (None). #p < 0.05, 
##p < 0.01, ###p < 0.001 versus the group with 50 
low left ventricular ejection fraction (LVEF) (a to 
d), versus the group with frequent ventricular 40 
ectopic beats (VE) (e) and versus the group with ~" 
runs ofventricular tachycardia (VT) (f). +p < 0.05, ~ 30 
+++p < 0.001 versus the group with depressed 
heart rate variability (HRV) (e and f). SAECG = o 20 
positive findings on the signal-averaged electrocar- = 
diogram. 1 0 
(a) 
None LVEF HRV Both 
Risk factors  I(d) **  
***  1 (b) 
None LVEFSAECGBoth 
Risk factors  
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Figure 2. Identification f patients with arrhythmic death (AD). First, 
patients in the lowest 5th, 10th, 15th, 20th, 25th and 30th percentiles 
for left ventricular ejection fraction (LVEF) were excluded (X axis). 
Then, from the remaining group, patients inthe lowest 20th percentile 
of heart rate variability (HRV) (a), highest 20th percentile of filtered 
QRS complex duration (TQRS) (b), ventricular ectopic beats (VE) (c) 
and ventricular tachycardia (VT) (d) were selected. The proportion of 
arrhythmic deaths i  indicated on the Y axis of the upper panel (solid 
bars) and the corresponding total cardiac mortality on the Y axis of the 
lower panel (open bars). 
patients with a normal ejection fraction, depressed heart rate 
variability was associated with nonarrhythmic death (p < 
0.001). A low ejection fraction had a significant impact on total 
cardiac (p < 0.05) and nonarrhythmic mortality (p < 0.001) 
but only in patients with normal heart rate variability. Ejection 
fraction was not a significant determinant of any mode of 
cardiac death in patients with depressed heart rate variability. 
The signal-averaged ECG was related to total cardiac (p < 
0.05) and nonarrhythmic mortality (p < 0.05) in patients with 
a normal left ventricular ejection fraction (Fig. lb). The 
combination of a positive signal-averaged ECG and a low 
ejection fraction was a predictor of arrhythmic death (p < 
0.05). A low ejection fraction was associated with total cardiac 
(p < 0.01) and nonarrhythmic mortality (p < 0.01) in patients 
with negative signal-averaged ECG findings. 
Frequent ventricular ectopic beats increased the risk of 
total cardiac mortality in patients with a normal (p < 0.01) or 
low (p < 0.001) left ventricular ejection fraction. This in- 
creased risk was predominantly due to an increased risk of 
nonarrhythmic death (p < 0.01 for patients with a normal or 
low ejection fraction, Fig. lc). The combination of frequent 
ventricular ectopic beats and a low ejection fraction greatly 
increased the risk of nonarrhythmic death. Together with a low 
left ventricular ejection fraction, ventricular ectopic beats also 
were associated with arrhythmic death (p < 0.01). 
The presence of runs of ventricular tachycardia was a 
predictor of total cardiac mortality in patients with a normal 
left ventricular ejection fraction (p < 0.05). Their presence was 
related to arrhythmic death in patients with a low ejection 
fraction (p < 0.05) but not in patients with a normal ejection 
fraction (Fig. ld). Also in this analysis, a low ejection fraction 
was associated with nonarrhythmic death (p < 0.001). 
When evaluating the combination of ventricular ectopic 
beats and heart rate variability, we found that depressed heart 
rate variability was associated with arrhythmic death in pa- 
tients with (p < 0.001) and without (p < 0.05) frequent 
ventricular ectopic beats (Fig. le). Ventricular ectopic beats 
were related to nonarrhythmic death in patients with a normal 
(p < 0.01) or depressed (p < 0.01) heart rate variability. 
Particularly, the combination of depressed heart rate variabil- 
ity and frequent ventricular ectopic beats resulted in a very 
marked increase in total cardiac (41%, p < 0.001) and 
nonarrhythmic (24%, p < 0.01) mortality. 
Figure if demonstrates that depressed heart rate variability 
was related to arrhythmic but also to nonarrhythmic death. In 
patients with depressed heart rate variability, runs of ventric- 
ular tachycardia were associated with arrhythmic death (p < 
0.05). The combination of runs of ventricular tachycardia and 
depressed heart rate variability was the most powerful predic- 
tor of cardiac death (total cardiac mortality 47%). This power 
was predominantly due to an increased risk of arrhythmic 
death (arrhythmic mortality 29%, p < 0.001) but also of nonar- 
rhythmic death (nonarrhythmic mortality 18%, p < 0.001). 
Identification of patients with arrhythmic or nonarrhyth- 
mic death. We attempted to stratify 20% of the total patient 
group with a high propensity for either arrhythmic or nonar- 
rhythmic death. When excluding patients with the lowest 
ejection fraction (i. e., patients at risk of nonarrhythmic death) 
and selecting patients with the lowest 20th percentile of heart 
rate variability, highest 20th percentile of filtered QRS com- 
plex duration, ventricular ectopic beats or ventricular tachy- 
cardias, the proportion of patients with arrhythmic death 
increased. In all combinations, the highest proportion of 
patients with arrhythmic death (71% to 75%) was stratified 
when we omitted patients belonging to the lowest 20th to 30th 
percentiles of ejection fraction (Fig. 2, a to d, upper panel). At 
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the peak proportion of arrhythmic deaths, the total cardiac 
mortality rates were 17%, 9%, 9% and 9%, respectively, for 
heart rate variability, filtered QRS-complex duration, ventric- 
ular ectopic beats and ventricular tachycardia runs (Fig. 2, a to 
d, lower panel). 
Correspondingly, by selecting patients with the lowest 20th 
percentile of left ventricular ejection fraction and excluding 
patients with the lowest heart rate variability, the proportion of 
patients with nonarrbythmic death increased, whereas the 
proportion of patients with an arrhythmic death decreased. 
The peak proportion of patients with nonarrhythmic death 
(75%) was achieved when patients with the lowest 20th 
percentile of heart rate variability were excluded (Fig. 3a, 
upper panel). However, omitting patients with depressed heart 
rate variability decreased total cardiac mortality. Thus, with 
the peak stratification of nonarrhythmic death, total cardiac 
mortality was 7% (Fig. 3a, lower panel). In contrast, exclusion 
of patients with the highest otal duration of QRS complex, a 
high number of ventricular ectopic beats and long runs of 
nonsustained ventricular tachycardia did not improve the 
identification of risk of nonarrhythmic death over that ob- 
tained with left ventricular ejection fraction alone (Fig. 3, b to 
d, upper panel). 
Finally, we studied further the distinction between arrhyth- 
mic and nonarrhythmic death. Because in the preceding anal- 
yses the combinations of heart rate variability and left ventric- 
ular ejection fraction provided the best distinction between 
arrhythmic and nonarrhythmic death, we repeated the strati- 
fication using these variables to select 10%, 15%, 20%, 25% 
and 30% of the patient group. We found that irrespective of 
the selected proportion of patients, the peak of arrhythmic 
mortality (up to 75% of cardiac deaths) was reached when the 
lowest 20th to 25th percentiles of left ventricular ejection 
fraction were excluded (Fig. 4a). Excluding patients with a low 
ejection fraction reduces total cardiac mortality. Nevertheless, 
excluding patients with the lowest 20th percentile of ejection 
fraction and selecting patients in the lowest 10th and 15th 
Figure 3. Identification ofpatients with nonarrhythmic death (NAD). 
First, patients in the lowest 5th, 10th, 15th, 20th, 25th and 30th 
percentiles for heart rate variability (HRV) were excluded (a). Then, 
from the remaining roup, patients in the lowest 20th percentile for 
left ventricular ejection fraction (LVEF) were selected. The same 
stratification was repeated but excluding the highest 5th, 10th, 15th, 
20th, 25th and 30th percentiles of filtered QRS complex duration 
(TQRS) (b), ventricular ectopic beats (VE) (c) and runs of ventricular 
tachycardia (VT) (d) and then selecting from the remaining patients a 
group in the lowest 20th percentile for left ventricular ejection fraction. 
The proportion of nonarrhythmic deaths i  indicated on the Y axis of 
the upper panel (solid bars) and corresponding total cardiac mortality 
on the Y axis of the lower panel (open bars). 
percentile heart rate variability groups, total cardiac mortality 
remained >20% and arrhythmic mortality >17% (Fig. 4b). 
Correspondingly, the peak of nonarrhythmic mortality (up to 
75% of cardiac deaths) was observed when the lowest 20th 
percentile of heart rate variability was excluded, and the 
groups with the lowest 15th or 20th percentile of ejection 
fraction were selected from the remaining patients (Fig. 5a). 
However, omitting patients with depressed heart rate variabil- 
ity significantly decreased cardiac mortality. Thus, at the peak 
stratification of nonarrhythmic death, the total cardiac mortal- 
ity rate was 9% and nonarrhythmic mortality rate 6.9% (Fig. 
5b). 
Discuss ion  
Prediction of the mechanism of cardiac death. Increasing 
attention has been focused on risk stratification studies to 
identify patients at high risk after acute myocardial infarction. 
Almost exclusively these studies have attempted to identify 
patients who are at high risk for sudden or arrhythmic death. 
Although sudden death and arrhythmias are responsible for a 
large proportion of deaths after myocardial infarction, identi- 
fication of patients at risk of nonarrhythmic death would be of 
clinical importance. In this study we demonstrated that estab- 
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Figure 4. Identification of patients with a high risk for arrhythmic 
death. First, patients in the lowest 5th, 10th, 15th, 20th, 25th and 30th 
percentiles for left ventricular ejection fraction (LVEF) (X axis) were 
excluded. From the remaining roup, patients in the lowest 10th, 15th, 
20th, 25th and 30th percentiles for heart rate variability (HRV) were 
selected, a, The Y axis illustrates the proportion of arrhythmic deaths 
(AD). b, The Y axis denotes absolute arrhythmic mortality using the 
same stratification as in panel a. 
Figure 5. Identification of patients with a high risk for nonarrhythmic 
deaths (NAD). First, patients in the lowest 5th, 10th, 15th, 20th, 25th 
and 30th percentiles for heart rate variability (HRV) (X axis) were 
excluded. From the remaining roup, patients in the lowest 10th, 15th, 
20th, 25th and 30th percentiles for left ventricular ejection fraction 
(LVEF) were selected, a, The Y axis illustrates the proportion of 
nonarrhythmic deaths, b, The Y axis denotes absolute nonarrhythmic 
mortality using the same stratification as in panel a. 
lished risk factors, such as depressed heart rate variability, 
positive signal-averaged ECG findings, ventricular arrhythmias 
during ambulatory ECG recording and low left ventricular 
ejection fraction, can provide different and supplementary 
information about the mechanism of death after myocardial 
infarction and that these risk factors can be combined to 
differentiate patients at risk of either arrhythmic or nonar- 
rhythmic death. 
In the univariate analysis, all the analyzed risk factors were 
significant predictors of cardiac mortality. With the exception 
of low left ventricular ejection fraction, all the other risk 
factors were associated with arrhythmic death. In fact, ana- 
lyzed as a continuous variable, ejection fraction also was a 
significant predictor of arrhythmic death. In this respect our 
results are in agreement with those of previous studies (1- 
8,10-14). 
According to previous tudies (2,3,6,11,17,18), a great pro- 
portion of patients have more than one risk factor after 
infarction. In our study, 28% of patients had at least two risk 
factors at the time of hospital discharge. Thus, the risk related 
to one risk factor is influenced by the concomitant presence of 
other risk factors. Consequently, the independent contribution 
of the risk factors to the mechanisms of death cannot be 
assessed without a multivariate approach. 
Arrhythmic death. The multivariate analysis clearly re- 
vealed that depressed low heart rate variability was an inde- 
pendent predictor of arrhythmic death. This was true for 
patients with either a low or a normal ejection fraction. This 
finding is in accord with previous tudies, in which depressed 
heart rate variability predicted inducibility of ventricular tachy- 
cardia during programmed ventricular stimulation (17) and 
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arrhythmic death during follow-up (1,2,17,19). In addition, 
runs of ventricular tachycardia during the 24-h ECG recording 
were related to arrhythmic death, a finding also in accord with 
earlier studies (10-12). In fact, the risk for arrhythmic death 
was highest (29%) in patients with both depressed heart rate 
variability and runs of ventricular tachycardia. 
Although there was a tendency to an increased propensity 
for arrhythmic death in patients with positive findings on the 
signal-averaged ECG, frequent ventricular ectopic beats and 
low left ventricular ejection fraction, in multivariate analysis 
these did not reach the level of statistical significance. In this 
respect our results may seem to contradict earlier studies 
(8,10-12). In a large multicenter study (14), low left ventricular 
ejection fraction was related to both total cardiac and arrhyth- 
mic mortality. In another study (13), low ejection fraction was 
the best noninvasive predictor of ventricular tachycardia nd 
sudden death in postinfarction patients. In those studies, 
however, the impact of heart rate variability was not analyzed. 
As we demonstrated, a great proportion of postinfarction 
patients with positive findings on the signal-averaged ECG, 
ventricular ectopic beats or low ejection fraction also have 
depressed heart rate variability. Thus, the independent contri- 
bution of risk cannot be assessed without evaluating all factors 
simultaneously. Indeed, also in our study when using the 
univariate approach, the signal-averaged ECG, ventricular 
ectopic beats and ejection fraction were related to arrhythmic 
death. This finding clearly highlights a significant interaction 
among different risk factors, a condition that complicates risk 
stratification in postinfarction patients. 
Nonarrhythmic death. Low left ventricular ejection fraction, 
depressed heart rate variability and ventricular ectopic beats 
were the only predictors of nonarrhythmic death. Figure 1 
shows that low ejection fraction was associated with nonar- 
rhythmic death, particularly in patients without depressed 
heart rate variability. Ventricular ectopic beats and, particu- 
larly, the combination of low ejection fraction and frequent 
ventricular ectopic beats turned out to be very powerful 
predictors of nonarrhythmic death. Low ejection fraction was 
found in 72% and frequent ventricular ectopic beats in 61% of 
patients who had a nonarrhythmic death. In contrast o some 
earlier studies (10-12), the presence of frequent ventricular 
ectopic beats was not associated with risk of arrhythmias but 
was indicative of left ventricular dysfunction. However, in the 
earlier studies multivariate analysis including heart rate vari- 
ability was not applied. Thus, it seems that ventricular ectopic 
beats and runs of ventricular tachycardia provide different 
information about the mechanism of death. Nonarrhythmic 
death was also related to depressed heart rate variability, which 
was identified in 72% of patients with nonarrhythmic death. 
Patients with the combination of depressed heart rate variabil- 
ity and frequent ventricular ectopic beats had the highest risk 
(24%) for nonarrhythmic death. It seems that some patients at 
risk of nonarrhythmic death can be identified by a low left 
ventricular ejection fraction. However, some patients with 
subsequent onarrhythmic death present with abnormal car- 
diovascular regulation that cannot be detected by means of 
impaired cardiac systolic function but becomes manifest as 
depressed heart rate variability or frequent ventricular ectopic 
beats. 
Distinction between arrhythmic and nonarrhythmic death. 
From a clinical point of view it is important to identify 
postinfarction patients who are at high risk of death. In 
addition, it would be of importance to predict he mechanism 
of death, because this might influence the treatment strategy. 
Patients with a high propensity for arrhythmic death may 
benefit from antiarrhythmic therapy or intervention, whereas 
such treatment may provide no benefit or even increase the 
risk of mortality in patients who are likely to die of a 
nonarrhythmic mechanism. An important implication of our 
study is that combined information of risk factors can be used 
to identify patient groups with a substantially high total cardiac 
mortality rate and a high proportion of either arrhythmic or 
nonarrhythmic deaths. By selecting patients with a high risk of 
arrhythmic death (depressed heart rate variability) and dese- 
lecting patients with a high risk of nonarrhythmic death (low 
ejection fraction), we were able to identify a patient group in 
which 75% of deaths were arrbythmic. Similarly, by selecting 
patients with the lowest ejection fraction and omitting patients 
with the lowest heart rate variability we were able to define a 
patient group having 75% of deaths due to nonarrhythmic 
mechanism. 
Methodologic considerations. The classification of deaths 
as arrhythmic or nonarrhythmic is of crucial importance in our 
study. The Cardiac Arrhythmia Pilot Study (CAPS) investiga- 
tors (19) have clearly shown the difficulties related to the 
classification of the primary mechanism of death after myocar- 
dial infarction. Most important, they concluded that sudden 
death is not necessarily equivalent to arrhythmic death. In the 
CAPS study, 55% of deaths were classified as arrhythmic, a 
proportion in close agreement with the 62% of arrhythmic 
deaths in our study. Our results also agree well with the rate of 
->50% reported in several earlier studies (19,20). 
Previous studies (3,4,17) have suggested that depressed 
baroreflex sensitivity bears the strongest association with in- 
duction of sustained monomorphic ventricular tachycardia and 
risk of arrhythmic death in patients recovering from an acute 
myocardial infarction. In our study, only a small number of 
patients underwent assessment of baroreflex sensitivity; there- 
fore, this important risk factor could not be included in our 
analysis. 
In previous risk stratification studies, the time domain 
standard eviation of normal RR intervals (SDNN) is perhaps 
most commonly used to assess heart rate variability. However, 
the heart rate variability index used in this study has been 
shown (25) to correlate highly with SDNN, and both indexes 
provide equivalent results for risk stratification. 
Conclusions. In this study we found a significant interac- 
tion among different risk factors used in risk stratification after 
myocardial infarction. We demonstrated that established risk 
factors provide supplementary information for risk stratifica- 
tion after myocardial infarction. In particular, we found that 
arrhythmic mortality was associated with depressed heart rate 
304 HARTIKAINEN ET AL JACC Vol. 28, No. 2 
ARRHYTHMIC AND NONARRHYTHMIC POSTINFARCTION DEATH August 1996:296-304 
variability and presence of runs of ventricular tachycardia 
during 24-h ECG recording. Low left ventricular ejection 
fraction, frequent ventrieular ectopic beats and depressed 
heart rate variability were related to risk of nonarrhythmic 
death. In addition, by using combined risk factors information 
we were able to identify patient groups in which up to 75% of 
deaths were either arrhythmic or nonarrhythmic. 
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